ACC app from Esperion Therapeutics integrates patient data for tailored cholesterol management

ACC app from Esperion Therapeutics integrates patient data for tailored cholesterol management
Esperion Therapeutics updates ACC app

Esperion Therapeutics has introduced an updated ACC Lipid Manager app aimed at guiding clinicians through the lipid-lowering process by integrating two essential tools: Lipid Lowering Therapy and Statin Intolerance, both rooted in ACC clinical policy.

The new digital tool allows healthcare providers to input individualized patient data, helping them to make evidence-based decisions for cholesterol management. The app is designed to enhance the clinical workflow and support adherence to recommended guidelines. Details on usage and further capabilities are available via the app link shared by the company.

Esperion has recently focused on expanding capabilities in cardiovascular care. The company earlier started a hiring push to drive innovation and growth in its cardiovascular care division. The new app release follows these efforts to strengthen its digital and clinical offerings.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.